Clinical Trial Update: Protective Effect of Aspirin on COVID-19 Patients [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update investigating the protective effect of aspirin in patients with COVID-19 across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Novel Coronavirus Pneumonia

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Xijing Hospital | Conditions: Novel Coronavirus Pneumonia, Aspirin | Phase 2, Phase 3 | Status: UNKNOWN